✦ LIBER ✦

Improving rates of surgery for lung cancer

✍ Scribed by The Lancet

Book ID: 117309482
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 122 KB
Volume: 378
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(11)61724-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genomic Surgery for Lung Cancer

✍ David S Schrump 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Improved outcomes associated with higher

Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer

✍ Stacy W. Gray; Mary Beth Landrum; Elizabeth B. Lamont; Barbara J. McNeil; Michae 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 785 KB

## Abstract ## BACKGROUND: Although surgery offers the greatest chance of a cure for patients with early stage nonsmall cell lung cancer (NSCLC), older and sicker patients often fail to undergo resection. The benefits of surgery in older patients and patients with multiple comorbidities are uncert

Improving Outcomes with Lung Cancer Surg

Improving Outcomes with Lung Cancer Surgery: Selective Referral or Quality Improvement?

✍ John D. Birkmeyer 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 137 KB

Improving survival rates for patients wi

Improving survival rates for patients with colorectal cancer

✍ Dr G. Jatzko; P. Lisborg; V. Wette 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 2 views

Surgery for small cell lung cancer

✍ Robert J. Ginsberg; Frances A. Shepherd 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Surgery for advanced stage lung cancer

✍ Dominique H. Grunenwald 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 3 views

Therapeutic strategy in advanced stage disease remains controversial. Theoretically resectable, Stage IIIa disease includes a high proportion of non-resectable nodal diseases. Overall 5-year survival after surgery remains lower than 15%. Randomized trials comparing the results of surgery alone with